# An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder

> **NCT01455961** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16000 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01455961
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 16000 (ACTUAL)
- **Last updated:** 2014-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455961, "An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01455961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*